Featured News
news cover
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
22 hours ago
news cover
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
22 hours ago
news cover
Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors
22 hours ago
news cover
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
08 Dec 2025
View more
Global Express
9 hours ago
Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions
Clinical Study
11 hours ago
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
Executive ChangeAcquisition
11 hours ago
Phillips Medisize Highlights Inhaled Drug Delivery Device Platforms and Scientific Insights at DDL 2025
Acquisition
11 hours ago
Artera Debuts ArteraAI Prostate Test (Post‑RP), Expanding its Oncology Portfolio
Phase 3Radiation Therapy
11 hours ago
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.